NIST traceable FTIR Wavelength Reference
Starna Scientific Ltd is the manufacturing headquarters of the Starna range of specialised products, which include photometer cells and accessories, optical components and Certified Reference materials to ISO/IEC 17025 standards.
Unique ISO/IEC 17025 FTIR Wavelength Reference
Polystyrene film has been used as a wavelength reference for infrared spectroscopy since the early days of the technique. For those laboratories using MidIR - FTIR in a regulated environment, Starna (Hainault, UK) can now supply polystyrene film references produced within the scope of Starna’s ISO Guide 34 accreditation and certified under ISO/IEC 17025, with full traceability to a NIST Standard Reference Material (SRM 1921b). They will also comply with the newest revisions of US Pharmacopoeia General Chapters 854 and 1854 on Mid-Infrared Spectroscopy.
The references are presented as card mounted films in the conventional industry pattern. Easy to use, they simply slip into the standard sample holder of any FTIR instrument. The accompanying Certificate of Calibration lists wavenumber values for 14 peaks from 539 cm-1 to 3082 cm-1 so can be used to qualify a MidIR - FTIR spectrophotometer for wavelength accuracy over an operating range of 3.2 µm to 18.5 µm.
The references are available with two film thicknesses. For qualifying MidIR - FTIR instruments, Starna RM-1921/38 is 38µm thick. Another version, RM-1921/65, is 65µm thick and has some additional peaks in the NIR.
For further information, contact Starna Scientific Ltd at sales@starna.com
Contact Details
Starna Scientific Ltd
52/54 Fowler Road
Hainault
Essex IG6 3UT
UK
Tel: +44 (0) 208 501 5550
Fax: +44 (0) 208 501 1118
Website:www.starna.comE-mail:sales@starna.com
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
